Frontiers in Oncology (Dec 2020)
Corrigendum: Down-Regulated FOXO1 in Refractory/Relapse Childhood B-Cell Acute Lymphoblastic Leukemia
- Qingqing Zheng,
- Chuang Jiang,
- Haiyan Liu,
- Wenge Hao,
- Pengfei Wang,
- Haiying Huang,
- Ziping Li,
- Jiabi Qian,
- Maoxiang Qian,
- Hui Zhang
Affiliations
- Qingqing Zheng
- Department of Hematology/Oncology, Guangzhou Women and Children’s Medical Center, Guangzhou, China
- Chuang Jiang
- Shanghai Children’s Medical Center, School of Medicine, Shanghai Jiao Tong University, Shanghai, China
- Haiyan Liu
- Department of Hematology/Oncology, Guangzhou Women and Children’s Medical Center, Guangzhou, China
- Wenge Hao
- Department of Hematology/Oncology, Guangzhou Women and Children’s Medical Center, Guangzhou, China
- Pengfei Wang
- Department of Hematology/Oncology, Guangzhou Women and Children’s Medical Center, Guangzhou, China
- Haiying Huang
- Department of Hematology/Oncology, Guangzhou Women and Children’s Medical Center, Guangzhou, China
- Ziping Li
- Department of Hematology/Oncology, Guangzhou Women and Children’s Medical Center, Guangzhou, China
- Jiabi Qian
- Department of Hematology/Oncology, Guangzhou Women and Children’s Medical Center, Guangzhou, China
- Maoxiang Qian
- Institute of Pediatrics and Department of Hematology and Oncology, Children’s Hospital of Fudan University, the Shanghai Key Laboratory of Medical Epigenetics, International Co-laboratory of Medical Epigenetics and Metabolism, Ministry of Science and Technology, Institutes of Biomedical Sciences, Fudan University, Shanghai, China
- Hui Zhang
- Department of Hematology/Oncology, Guangzhou Women and Children’s Medical Center, Guangzhou, China
- DOI
- https://doi.org/10.3389/fonc.2020.629875
- Journal volume & issue
-
Vol. 10
Abstract
No abstracts available.Keywords
